BackChapter 20: Infectious Diseases Manifesting in the Nervous System – Structure, Defenses, and Major Pathogens
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
20.1 The Nervous System, Its Defenses, and Normal Biota
Overview of the Nervous System
The nervous system is divided into two main components, each with distinct anatomical and functional roles. Understanding these divisions is essential for appreciating how infectious diseases can impact neural tissues.
Central Nervous System (CNS): Composed of the brain and spinal cord, responsible for processing and integrating information.
Peripheral Nervous System (PNS): Consists of nerves emanating from the CNS to sense organs and peripheral tissues.
Functions of the Nervous System
Sensory: Sensory receptors at peripheral nerve endings generate impulses transmitted to the CNS.
Integrative: The CNS translates impulses into sensations or thoughts and drives motor functions.
Motor: Involves activation of muscles and glands.
Protective Structures and Fluids
Bone: The brain is encased in the skull; the spinal cord is protected by the vertebral column.
Meninges: Three protective membranes surrounding the CNS: dura mater, arachnoid mater, and pia mater.
Cerebrospinal Fluid (CSF): Fills the subarachnoid space, provides nutrition, and acts as a cushion for the brain and spinal cord.
Defenses of the Nervous System
Bony casings: Protect against traumatic injury.
CSF: Serves as a shock absorber.
Blood–Brain Barrier: Specialized endothelial cells restrict passage of most molecules and microbes into the CNS, making infections rare but also complicating drug delivery.
Specialized Immune Cells
Microglial cells: CNS-resident phagocytes.
Brain macrophages: Present but less active than peripheral phagocytes.
Nervous System | Defenses | Normal Biota |
|---|---|---|
CNS & PNS | Bony structures, blood–brain barrier, microglial cells, macrophages | None |
Normal Biota and the Gut–Brain Axis
The CNS and PNS are considered sterile; detection of microbes indicates pathology.
Emerging evidence suggests the gut microbiome may influence CNS function and autoimmunity (the gut–brain axis).
20.2 Infectious Diseases Manifesting in the Nervous System
Overview of Meningitis
Meningitis is inflammation of the meninges, most often caused by bacteria, but also by viruses and fungi. Rapid diagnosis and treatment are critical due to the risk of severe neurological damage or death.
Symptoms: Fever, headache, stiff neck, nausea, vomiting, photophobia, seizures, altered mental status.
Pathogenesis: Virulence factors enable pathogens to penetrate the blood–brain barrier.
Major Bacterial Causes of Meningitis
Neisseria meningitidis: Gram-negative diplococcus, significant cause of epidemic meningitis. Virulence factors include capsule, endotoxin, and IgA protease. Diagnosed by Gram stain, culture, and oxidase test.
Streptococcus pneumoniae: Gram-positive, encapsulated coccus, leading cause of community-acquired meningitis. Produces alpha-hemolysin and hydrogen peroxide. Two vaccines available.
Haemophilus influenzae (type b): Gram-negative coccobacillus, historically a major cause, now rare due to vaccination.
Listeria monocytogenes: Gram-positive rod, grows in cold, heat, salt, and bile; can cross placenta, causing fetal death. Associated with contaminated dairy, poultry, and meat.
Major Fungal Causes of Meningitis
Cryptococcus neoformans: Encapsulated yeast, causes chronic meningitis, especially in immunocompromised patients. Transmitted via bird droppings.
Coccidioides spp.: Dimorphic fungus ("Valley Fever"), endemic in the Americas. Forms spherules in tissue; inhalation of spores is the main route.
Viral Meningitis
Accounts for the majority of meningitis cases ("aseptic meningitis").
Most common in children; 90% caused by enteroviruses.
Generally milder than bacterial or fungal forms; resolves in about two weeks.
Meningitis Disease Table
Causative Organism(s) | Most Common Modes of Transmission | Virulence Factors | Culture/Diagnosis | Prevention | Treatment | Distinctive Features | Epidemiological Features |
|---|---|---|---|---|---|---|---|
Neisseria meningitidis | Droplet contact | Capsule, endotoxin, IgA protease | Gram stain/culture of CSF, blood, rapid antigen tests | Conjugated vaccine, prophylactic antibiotics | Penicillin G, ceftriaxone | Petechiae, rapid decline | Highest incidence in children/young adults |
Streptococcus pneumoniae | Droplet contact | Capsule, alpha-hemolysin, hydrogen peroxide | Gram stain/culture of CSF | Two vaccines (Prevnar, Pneumovax) | Ceftriaxone, vancomycin | No petechiae, underlying susceptibility | Most common in adults |
Haemophilus influenzae | Droplet contact | Capsule | Cultured on chocolate agar | Hib vaccine | Ceftriaxone | Severe, rapid onset | Rare in vaccinated populations |
Listeria monocytogenes | Vehicle (food) | Intracellular growth | Cold enrichment, rapid methods | Cooking food, avoiding unpasteurized dairy | Ampicillin, gentamicin | Asymptomatic in healthy adults | High mortality in neonates, elderly |
Cryptococcus neoformans | Vehicle (air, dust) | Capsule, melanin production | Negative staining, biochemical tests | N/A | Amphotericin B, flucytosine | Chronic, common in AIDS patients | 90% of infections in HIV+ patients |
Coccidioides spp. | Vehicle (air, dust, soil) | Granuloma (spherule) formation | Identification of spherules, Sabouraud's agar | Avoiding airborne exposure | Fluconazole, amphotericin B | Endemic regions only | 200–300 cases/year in endemic areas |
Viruses | Droplet contact | Lytic infection of host cells | Viral culture, antigen tests | N/A | Supportive care | Milder than bacterial/fungal | 26,000–42,000 hospitalizations/year in US |
Neonatal and Infant Meningitis
Usually transmitted from mother to infant during birth or in utero.
Most common causes: Streptococcus agalactiae (Group B strep), Escherichia coli (K1 strain), and Listeria monocytogenes.
Premature infants are at higher risk; mortality rates have declined but morbidity remains significant.
Causative Organism(s) | Most Common Modes of Transmission | Virulence Factors | Culture/Diagnosis | Prevention | Treatment | Distinctive Features | Epidemiological Features |
|---|---|---|---|---|---|---|---|
Streptococcus agalactiae | Vertical (during birth) | Capsule | Culture mother’s genital tract, CSF culture of infant | Chemoprophylaxis of mother | Penicillin G plus aminoglycosides | Most common; positive culture of mother confirms diagnosis | Colonizes 10–30% of women |
Escherichia coli (K1) | Vertical (during birth) | Capsule | CSF Gram stain/culture | N/A | Cefotaxime or combination therapy | Suspected if infant is premature | 20% mortality in premature infants |
Listeria monocytogenes | Vertical | Intracellular growth | Cold enrichment, rapid methods | Cooking food, avoiding unpasteurized dairy | Ampicillin, gentamicin | Asymptomatic in healthy adults | High mortality in neonates |
Meningoencephalitis
Definition: Inflammation of both the brain and meninges.
Causative agents: Amoebas such as Naegleria fowleri (primary amoebic meningoencephalitis) and Acanthamoeba (granulomatous amoebic meningoencephalitis).
Causative Organism(s) | Most Common Modes of Transmission | Virulence Factors | Culture/Diagnosis | Prevention | Treatment | Epidemiological Features |
|---|---|---|---|---|---|---|
Naegleria fowleri | Vehicle (exposure to warm freshwater) | Invasiveness | CSF exam, brain imaging, biopsy | Avoid swimming in warm, untreated water | Pentamidine, sulfadiazine | Rare, almost always fatal |
Acanthamoeba | Direct contact | Invasiveness | CSF exam, brain imaging, biopsy | N/A | Surgical excision, pentamidine | Immunocompromised patients |